Elyse Stock

Insider Reports History

Location
New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elyse Stock:

Company Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Common Shares 0 $148.50 03 Oct 2022 By Spouse
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Common Shares 0 $148.50 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Restricted Share Unit Award 0 03 Oct 2022 By Spouse
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Restricted Share Unit Award 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Stock Options (Right to Buy) 0 03 Oct 2022 By Spouse
Biohaven Pharmaceutical Holding Co Ltd. Chief Medical Officer Stock Options (Right to Buy) 0 03 Oct 2022 Direct

Insider Reports Filed by Elyse Stock

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000156218022006951-stock-elyse-2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 22 -$2,444,904 4 Chief Medical Officer 03 Oct 2022, 20:23
/report/000156218022000439-stock-elyse-2022-01-10 Biohaven Pharmaceutical Holding Co Ltd. 10 Jan 2022 2 $0 4 Chief Medical Officer 12 Jan 2022, 20:10
/report/000156218022000352-stock-elyse-2022-01-06 Biohaven Pharmaceutical Holding Co Ltd. 06 Jan 2022 13 -$425,986 4 Chief Medical Officer 07 Jan 2022, 20:17
/report/000156218021007738-stock-elyse-2021-12-14 Biohaven Pharmaceutical Holding Co Ltd. 14 Dec 2021 11 -$2,625,376 4 Chief Medical Officer 16 Dec 2021, 20:04
/report/000156218021007303-stock-elyse-2021-11-25 Biohaven Pharmaceutical Holding Co Ltd. 25 Nov 2021 3 -$184,764 4 Chief Medical Officer 26 Nov 2021, 15:33